Healthcare & Life Sciences
ExCulture
Netherlandsexculturebiotech.com
ExCulture is a startup. 1 investor tracked.
Activeseed
seed
Stage
2019
Founded
1
Investors
About ExCulture
ExCulture is a company founded in 2019 headquartered in the Netherlands. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
ExCulture specializes in fermentation bioprocess technology to develop an animal-free substitute for heparin, a critical blood thinner, using a mixed-culture fermentation process.
Explore ExCulture's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.